Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Clinical trial NCT04975438 · COMPLETED

Trial details

NCT number: NCT04975438
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2021-11-18
Primary completion: 2022-12-19
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.